Chicago-based Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has raised $100 million in financing. The backers included Baillie Gifford, Franklin Templeton, NEA, Novo Holdings and funds and accounts managed by T. Rowe Price.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: